A retrospective study of 27 ovarian tumors of low malignant potential

Introduction: This study was undertaken to retrospectively review the fertility-sparing surgical treatment and long-term outcome of 27 patients with ovarian tumors of low malignant potential treated at the 1st Department of Obstetrics and Gynecology of Semmelweis University Faculty of Medicine between 1990 and 2000.

Materials and methods: Between 1990 and 2000, 163 patients with epithelial ovarian tumors were diagnosed and treated. Of these, 27 patients were diagnosed as having low malignant potential (LMP) ovarian tumors. The authors evalutated the effect of histopathologic parameters (histologic type, grade of nuclear atypia, tumor size and tumor growth on the ovarian surface) and clinical parameters (age at diagnosis, stage of disease, and treatment modalities) on prognosis in this group of patients with a long observation time. We reviewed our experience to assess the safety of conservative surgical management of patients younger than age 40 with early stage disease, and to determine the long-term outcome of low malignant potential ovarian tumors. Medical records were reviewed on all 27 patients to determine age, gravidity, size of tumor, bilaterality, sites of extraovarian involvement, stage of disease and the operative procedure. Follow-up information was obtained from hospital records, and in some cases, by direct patient contact. Statistical comparisions were made by the chi2 test.

Results: The incidence of LMP tumors in our patient population was 16.5%. The patients ranged in age from 15 to 82 years (median, 45 years). The lesions were staged according to FIGO. The stage distribution was Stage IA in 20 patients, Stage IB in one patient, Stage IC in one patient, Stage IIA in one patient, Stage IIB in one patient, Stage IIC in one patient and Stage IIIA in two patients. The ovarian tumors ranged in size from 3 to 19 cm (median 9 cm) and 15% of the tumors were bilateral. All patients with LMP ovarian tumors were treated with primary surgery; those who were older than 40 (14 patients) were treated with total trans-abdominal hysterectomy and bilateral salpingo-oophorectomy (TAH and BSO), while patients younger than 40 with early stage disease (12 patients) who wished to retain their fertility potential were treated with fertility-sparing surgery, namely unilateral salpingo-oophorectomy (USO). One patient who was younger than 40 with a Stage IIIA LMP ovarian tumor was also treated with TAH and BSO. Follow-up information was available for all 27 patients with LMP ovarian tumors. Only those patients with a minimum of two years of follow-up were included. Follow-up information from two to ten years (median, 6 years; mean, 6.5 years) revealed that all 27 patients were alive. During the period of follow-up one patient who initially had stage IIIA disease developed recurrent tumor. Fifty percent of patients who underwent conservative fertility-sparing surgical treatment (6/12) subsequently conceived.

Conclusions: This study confirms the excellent prognosis for patients with low malignant potential ovarian tumors. Conservative fertility-saving surgical treatment can be offered to young patients (< 40 years) with early stage (stage I-II) disease who wish to retain their fertility potential. Up to 50% of women in this study who underwent conservative surgery subsequently conceived. The long-term outcome of LMP ovarian tumors is extremely favorable, even when long-term follow-up is extended to ten years.

Ovarian tumor of low malignant potential; Fertility preservation

[1] International F ederation of Gynecology and Obstetrics: Classification and strategy of malignant tumors in the female pelvis. Acta Obstet. Gynecol. Scand., 1977, 50, 1.

[2] Taylor H. C.: "Malignant and semimalignant tumors of the ovary" Surg. Gynecol. Obstet., 1929, 48, 702.

[3] Bostwick D. G. et al.: "Ovarian epithelial tumors of borderline malignancy: a clinical and pathologic study of 109 cases". Cancer, 1986, 58, 2052.

[4] Casey A.C . et al.: "Epitheliial ovarian tumors of borderline malignancy: long-term follow-up". Gynecol. Oncol., 1993, 50(3), 316.

[5] JChambers J. T. et al.: "Borderline ovarian tumors". Am. J. Obstet. Gynecol., 1988, 159, 1088.

[6] Rice L. W. et al.: "Epithelial ovarian tumors of borderline malignancy". Gynecol. Oncol., 1990, 39 (2), 195.

[7] Norris H.J.: "Proliferative endometrioid tumors and endometrioid tumors of low malignant potential of the ovary". Int. J. Gynecol. Pathol., 1993, 12 (2), 134.

[8] Piura B. et al.: "Epithelial ovarian tumors of borderline malignancy: a study of 50 cases". Int. J. Gynecol. Cancer, 1992, 2 (2), 189.

[9] NIH Consensus Development Panel on Ovarian Cancer: "Ovarian cancer: screening, treatment, and follow-up". J.A.M.A., 1995, 273, 491.

[10] Barnhill D. R. et al.: "Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study". J. Clin. Oncol., 1995, 13 (11), 2752.

[11] Barnhill D.R. et al.: "Epithelial ovarian carcinoma of low malignant potential". Obstet. Gynecol., 1985, 65 (1), 53.

[12] Kurman R. J. et al.: "The behaviour of serous tumors of low malignant potential: are they ever malignant?". Int. J. Gynecol. Pathol., 1993, 12 (2), 120.

[13] Bell D. A. et al.: "Peritoneal implants of ovarian serous borderline tumors". Cancer, 1986, 58, 2052.

[14] Tamakoshi K. et al.: "Clinical behavior of borderline ovarian tumors: a study of 150 cases". J. Surg. Oncol., 1997, 64 (2), 147.

[15] Koern J. et al.: "A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982". Cancer, 1993, 71 (5), 1810.

[16] Leake J. F. et al.: "Long-term follow-up of serous ovarian tumors of low malignant potential". Gynecol. Oncol., 1992, 47 (2), 150.

[17] Morice P. et al.: "Clinical outcomes and fertility after conservative treatment of borderline ovarian tumors". Fert. Steril., 2001, 75 (1), 92.

[18] de Nictolis M. et al.: "Serous borderline tumors of the ovary". Cancer, 1992, 70 (1), 152.

[19] Russel P.: "Borderline epithelial tumours of the ovary: a conceptual dilemma". Clin. Obset. Gynecol., 1984, 11, 259.

[20] Bell D. A. et al.: "Serous borderline tumors of the peritoneum". Am. J. Surg. Path., 1990, 14, 230.

[21] Barakat R.R. et al.: "Platinium based chemotherapy for advanced stage serous ovarian cancers of low malignant potential". Gynecol. Oncol., 1995, 59, 390.

[22] F ort M. G. et al.: "Evidence for the efficacy of adjuvant therapy in epithelial ovarian tumors of low malignant potential". Gynecol. Oncol., 1989, 32 (2), 269.

[23] Gerhenson D. M. et al.: "Serous ovarian tumors of low malignant potential with peritoneal implants". Cancer, 1990, 65 (3), 578.

[24] Sutton G. P. et al.: "Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy (a Gynecologic Oncology Group study)". Gynecol. Oncol., 1991, 41 (3), 230.

[25] Trope C. et al.: "Are borderline tumors of the ovary overtreated both surgically and systematically? A review of four prospective randomized trials including 253 patients with borderline tumors". Gynecol. Oncol., 1993, 51 (2), 236.

[26] Leake J. F. et al.: "Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential". Gynecol. Oncol., 1991, 42 (2), 124.